The global sales of the Neurovascular Devices Market in 2022 were held at US$ 3.1 Bn. With a CAGR of 7.6% during 2023 - 2033, the market is projected to reach a valuation of US$ 7 Bn by 2033.
Cerebral Embolization and Aneurysm Coiling Devices are expected to be the highest revenue-generating segment, projected to grow at a CAGR of around 9% during 2023 – 2033.
As per the neurovascular devices market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of neurovascular devices increased at around 6.8% CAGR.
A neurological device is a non-surgical specialty that treats the most complicated and hazardous illnesses of the neck, brain, and spine with minimally invasive, image-guided procedures. Neurosurgery is a surgical practice or specialization for the treatment of neurovascular disorders. Neurology is a discipline of medicine that deals with problems of the nervous system and brain as a whole.
It deals with the treatment and diagnosis of various peripheral and central nervous system disorders. The weakening of arteries can lead to cerebral hemorrhage and the formation of brain aneurysms. Adult impairment is mostly caused by neurovascular disease.
However, advances in technology are assisting healthcare providers in reducing the burden of neurovascular illness. In order to obtain the particular qualities for aneurysm repair and ischemic stroke prevention, a range of materials such as nitinol, cobalt, and platinum can be employed in neurovascular devices.
The worldwide neurovascular devices industry is being driven by the rising incidence of neurovascular illnesses among people throughout the world, as well as the growing elderly population. In addition, the growing demand for less invasive surgical techniques is supporting the worldwide market's expansion.
Furthermore, continuous product developments and rising commercialization efforts are likely to contribute significantly to the worldwide market's growth throughout the forecast period.
The worldwide neurovascular devices market's growth is being hampered by strict regulations and expensive device costs. Over the projected period, however, increased investments in the growth and development of advanced healthcare infrastructure, particularly in emerging nations, are likely to provide profitable prospects for key players in the worldwide market.
The development and growing acceptance of neurovascular devices has resulted from greater government funding in the creation of sophisticated healthcare infrastructure and increased industry involvement in research and development efforts. The presence of technologically sophisticated neurovascular devices has considerably contributed to the market expansion by allowing enhanced treatments for different neurological illnesses.
Increased demand for embolization devices will be driven by an increase in the occurrences of brain aneurysms, and approval of innovative devices, which will consequently drive the neurovascular devices industry. Apart from this, the growing prevalence of hypertension throughout the world, which may lead to brain aneurysms, is likely to propel the market.
Covid-19 had a significant impact on the market for Neurovascular Devices due to the postponement of elective procedures. Undiagnosed and unreported incidences of brain aneurysms also hurt the Neurovascular Devices industry. Reduced postoperative discomfort and quicker recovery are driving the use of minimally invasive operations and fuelling R&D in this sector. Furthermore, people infected with Covid-19 infection have later developed symptoms of neurological disorders that are most likely to create conditions for market expansion.
Growing obesity and the aging population, as well as technical advancements in the field of interventional neurology, are the primary driving factors for the worldwide neurovascular devices market. The expansion of the market may be due to a growing patient pool for hemorrhagic and ischemic stroke, as well as an increase in demand for minimally invasive methods to treat neurovascular illness.
In 2022, North America held the largest share of the global market. The rise in the senior population is a significant factor driving the growth of neurovascular devices in the region. Furthermore, the rise in the frequency of neurovascular illnesses and the use of neurovascular devices contribute to the growth of the neurovascular devices market in the region. Other reasons, such as the increase in technical breakthroughs linked to neurovascular devices, also contribute to the market's growth in the United States.
Asia Pacific is anticipated to be the most opportune market over the projection period. Rising expenditure on healthcare and increasing disposable income are driving the use of neurovascular devices in the area. Furthermore, increased government spending in the area to construct advanced healthcare infrastructure is likely to fuel market growth in the near future.
By the end of 2033, the United States is expected to have the largest market of US$ 1.6 Bn. It previously grew at a CAGR of 7.4% from 2018 to 2022 and is expected to grow at a CAGR of 7.5% over the forecasted period. This can be ascribed to a variety of variables, including the region's established healthcare infrastructure, higher healthcare expenditures, increased awareness of neurological illnesses, and the region's expanding senior population. The existence of multiple leading companies in the region, as well as their diverse development strategies, has a substantial impact on market growth.
The market in the U.K. is expected to reach a valuation of US$ 259 Mn by 2033, growing at a CAGR of 9% during 2023 – 2033. The market is projected to gross an absolute dollar opportunity of US$ 148 Mn during the forecast period.
In Japan, the market is expected to reach a valuation of US$ 240 Mn by 2033. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of US$ 124 Mn, growing at a CAGR of 7.4%.
The market in South Korea is projected to grow at a CAGR of 6.7% during 2023 – 2033. During this period, the market is projected to witness an absolute dollar opportunity of US$ 65.3 Mn and reach US$ 135 Mn by 2033.
Cerebral Embolization and Aneurysm Coiling Devices commanded the largest revenue, grew at a CAGR of nearly 7.8% during 2018-22, and are forecasted to grow at a CAGR of 9% throughout the forecasted period.
This is due to the rising occurrence of numerous neurological illnesses in the population, such as arteriovenous malformations, brain aneurysms, and strokes. Furthermore, rising expenditures in the creation of enhanced healthcare infrastructure, rising consumer expenditure on healthcare, and rising research and development investments are key factors driving this segment's growth.
Market revenue through Stroke commanded the largest revenue and grew at a CAGR of nearly 7.3% during 2018-22, and is forecasted to grow at a CAGR of 8.2% throughout the forecasted period.
The rising occurrence of strokes among the population, particularly among the elderly, has fueled this segment's expansion. It is also the second leading cause of death in the United States. As a result, this market segment is likely to maintain its dominance during the forecast period. Furthermore, the government's and other NGOs' increasing efforts to raise awareness about neurological illnesses are boosting the segment's growth. The market is growing due to new product introductions linked to stroke therapies.
The competitors in the neurovascular devices market are attempting to achieve a larger market share by implementing tactics, such as investments, collaborations, and acquisitions & mergers. Companies are also spending on the creation of enhanced products. Some of the recent developments of key neurovascular devices providers are as follows:
Similarly, recent developments related to companies in the neurovascular devices services have been tracked by the team at Transparency Market Research, which is available in the full report.
By Product Type
By Therapeutic Application
By Region
|
Attribute |
Details |
|
Global Neurovascular Devices Market (2023) |
US$ 3.1 Bn |
|
Global Neurovascular Devices Industry (2033) |
US$ 7 Bn |
|
Global Market CAGR (2023 - 2033) |
7.6% |
|
U.S. Neurovascular Devices Market CAGR (2023 - 2033) |
7.5% |
|
Key Companies Profiled |
|
The global market is worth more than US$ 3.1 Bn at present
The market value is projected to increase at a CAGR of around 7.6% during 2023 – 2033.
The market value increased at a CAGR of around 6.8% during 2018 – 2022.
Rising incidence of neurovascular illnesses and continuous product developments and rising commercialization are bolstering the growth.
The market for neurovascular devices market in China is projected to expand at a CAGR of around 9.6% during 2023 – 2033.
While the market in South Korea is expected to grow at nearly 6.7%, the market in Japan is projected to register a CAGR of nearly 7.4% during 2023 - 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Bn) & Volume (Units) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Device Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Device Type, 2018-2022
5.3. Current and Future Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Device Type, 2023-2033
5.3.1. Cerebral Embolization and Aneurysm Coiling Devices
5.3.1.1. Embolic Coils
5.3.1.2. Flow Diversion Devices
5.3.1.3. Liquid Embolic Agents
5.3.2. Cerebral Angioplasty and Stenting Systems
5.3.2.1. Carotid Artery Stents
5.3.2.2. Embolic protection
5.3.3. Neurothrombectomy Devices
5.3.3.1. Clot Retrieval Devices
5.3.3.2. Suction Devices
5.3.3.3. Vascular Snares
5.3.4. Support Devices
5.3.4.1. Micro Catheters
5.3.4.2. Micro Guidewires
5.4. Y-o-Y Growth Trend Analysis By Device Type, 2018-2022
5.5. Absolute $ Opportunity Analysis By Device Type, 2023-2033
6. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Therapeutic Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Therapeutic Application, 2018-2022
6.3. Current and Future Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Therapeutic Application, 2023-2033
6.3.1. Stroke
6.3.1.1. Cerebral Artery Stenosis
6.3.1.2. Cerebral Aneurysm
6.3.1.3. Other Therapeutic Applications
6.3.2. Cerebral Artery Stenosis
6.3.3. Cerebral Aneurysm
6.3.4. Other Therapeutic Applications
6.4. Y-o-Y Growth Trend Analysis By Therapeutic Application, 2018-2022
6.5. Absolute $ Opportunity Analysis By Therapeutic Application, 2023-2033
7. Global Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Bn) & Volume (Units) Analysis By Region, 2018-2022
7.3. Current Market Size Value (US$ Bn) & Volume (Units) Analysis and Forecast By Region, 2023-2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
8.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
8.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
8.2.1. By Country
8.2.1.1. Value (US$ Bn) & Volume (Units)ed States
8.2.1.2. Canada
8.2.2. By Device Type
8.2.3. By Therapeutic Application
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Device Type
8.3.3. By Therapeutic Application
8.4. Key Takeaways
9. Latin America Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
9.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
9.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Device Type
9.2.3. By Therapeutic Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Device Type
9.3.3. By Therapeutic Application
9.4. Key Takeaways
10. Europe Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Russia
10.2.1.7. Rest of Europe
10.2.2. By Device Type
10.2.3. By Therapeutic Application
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Device Type
10.3.3. By Therapeutic Application
10.4. Key Takeaways
11. Asia Pacific Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. India
11.2.1.4. South Korea
11.2.1.5. Australia
11.2.1.6. Rest of APAC
11.2.2. By Device Type
11.2.3. By Therapeutic Application
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Device Type
11.3.3. By Therapeutic Application
11.4. Key Takeaways
12. MEA Neurovascular Devices Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Bn) & Volume (Units) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Bn) & Volume (Units) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. South Africa
12.2.1.2. Saudi Arabia
12.2.1.3. UAE
12.2.1.4. Israel
12.2.1.5. Rest of MEA
12.2.2. By Device Type
12.2.3. By Therapeutic Application
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Device Type
12.3.3. By Therapeutic Application
12.4. Key Takeaways
13. Key Countries Neurovascular Devices Market Analysis
13.1. Value (US$ Bn) & Volume (Units)ed States
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Device Type
13.1.2.2. By Therapeutic Application
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Device Type
13.2.2.2. By Therapeutic Application
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Device Type
13.3.2.2. By Therapeutic Application
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Device Type
13.4.2.2. By Therapeutic Application
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Device Type
13.5.2.2. By Therapeutic Application
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Device Type
13.6.2.2. By Therapeutic Application
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Device Type
13.7.2.2. By Therapeutic Application
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Device Type
13.8.2.2. By Therapeutic Application
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Device Type
13.9.2.2. By Therapeutic Application
13.10. Russia
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Device Type
13.10.2.2. By Therapeutic Application
13.11. China
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Device Type
13.11.2.2. By Therapeutic Application
13.12. Japan
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Device Type
13.12.2.2. By Therapeutic Application
13.13. India
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Device Type
13.13.2.2. By Therapeutic Application
13.14. South Korea
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Device Type
13.14.2.2. By Therapeutic Application
13.15. Australia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Device Type
13.15.2.2. By Therapeutic Application
13.16. South Africa
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2022
13.16.2.1. By Device Type
13.16.2.2. By Therapeutic Application
13.17. Saudi Arabia
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2022
13.17.2.1. By Device Type
13.17.2.2. By Therapeutic Application
13.18. UAE
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2022
13.18.2.1. By Device Type
13.18.2.2. By Therapeutic Application
13.19. Israel
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2022
13.19.2.1. By Device Type
13.19.2.2. By Therapeutic Application
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Device Type
14.3.3. By Therapeutic Application
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Medtronic
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. Microport Scientific Corporation
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. Penumbra Inc
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. Stryker
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. Johnson & Johnson Services Inc
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
15.1.6. MicroVention, Inc.
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.6.5.3. Channel Strategy
15.1.7. Integra LifeSciences Corporation
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.7.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
List of Tables
Table 1: Global Neurovascular Devices Market Value (US$ Bn) Forecast by Region, 2018-2033
Table 2: Global Neurovascular Devices Market Volume (Units) Forecast by Region, 2018-2033
Table 3: Global Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033
Table 4: Global Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033
Table 5: Global Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033
Table 6: Global Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033
Table 7: North America Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 8: North America Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033
Table 9: North America Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033
Table 10: North America Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033
Table 11: North America Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033
Table 12: North America Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033
Table 13: Latin America Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 14: Latin America Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033
Table 15: Latin America Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033
Table 16: Latin America Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033
Table 17: Latin America Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033
Table 18: Latin America Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033
Table 19: Europe Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 20: Europe Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033
Table 21: Europe Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033
Table 22: Europe Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033
Table 23: Europe Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033
Table 24: Europe Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033
Table 25: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 26: Asia Pacific Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033
Table 27: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033
Table 28: Asia Pacific Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033
Table 29: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033
Table 30: Asia Pacific Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033
Table 31: MEA Neurovascular Devices Market Value (US$ Bn) Forecast by Country, 2018-2033
Table 32: MEA Neurovascular Devices Market Volume (Units) Forecast by Country, 2018-2033
Table 33: MEA Neurovascular Devices Market Value (US$ Bn) Forecast by Device Type, 2018-2033
Table 34: MEA Neurovascular Devices Market Volume (Units) Forecast by Device Type, 2018-2033
Table 35: MEA Neurovascular Devices Market Value (US$ Bn) Forecast by Therapeutic Application, 2018-2033
Table 36: MEA Neurovascular Devices Market Volume (Units) Forecast by Therapeutic Application, 2018-2033
List of Figures
Figure 1: Global Neurovascular Devices Market Value (US$ Bn) by Device Type, 2023-2033
Figure 2: Global Neurovascular Devices Market Value (US$ Bn) by Therapeutic Application, 2023-2033
Figure 3: Global Neurovascular Devices Market Value (US$ Bn) by Region, 2023-2033
Figure 4: Global Neurovascular Devices Market Value (US$ Bn) Analysis by Region, 2018-2033
Figure 5: Global Neurovascular Devices Market Volume (Units) Analysis by Region, 2018-2033
Figure 6: Global Neurovascular Devices Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 7: Global Neurovascular Devices Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 8: Global Neurovascular Devices Market Value (US$ Bn) Analysis by Device Type, 2018-2033
Figure 9: Global Neurovascular Devices Market Volume (Units) Analysis by Device Type, 2018-2033
Figure 10: Global Neurovascular Devices Market Value Share (%) and BPS Analysis by Device Type, 2023-2033
Figure 11: Global Neurovascular Devices Market Y-o-Y Growth (%) Projections by Device Type, 2023-2033
Figure 12: Global Neurovascular Devices Market Value (US$ Bn) Analysis by Therapeutic Application, 2018-2033
Figure 13: Global Neurovascular Devices Market Volume (Units) Analysis by Therapeutic Application, 2018-2033
Figure 14: Global Neurovascular Devices Market Value Share (%) and BPS Analysis by Therapeutic Application, 2023-2033
Figure 15: Global Neurovascular Devices Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2023-2033
Figure 16: Global Neurovascular Devices Market Attractiveness by Device Type, 2023-2033
Figure 17: Global Neurovascular Devices Market Attractiveness by Therapeutic Application, 2023-2033
Figure 18: Global Neurovascular Devices Market Attractiveness by Region, 2023-2033
Figure 19: North America Neurovascular Devices Market Value (US$ Bn) by Device Type, 2023-2033
Figure 20: North America Neurovascular Devices Market Value (US$ Bn) by Therapeutic Application, 2023-2033
Figure 21: North America Neurovascular Devices Market Value (US$ Bn) by Country, 2023-2033
Figure 22: North America Neurovascular Devices Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 23: North America Neurovascular Devices Market Volume (Units) Analysis by Country, 2018-2033
Figure 24: North America Neurovascular Devices Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 25: North America Neurovascular Devices Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 26: North America Neurovascular Devices Market Value (US$ Bn) Analysis by Device Type, 2018-2033
Figure 27: North America Neurovascular Devices Market Volume (Units) Analysis by Device Type, 2018-2033
Figure 28: North America Neurovascular Devices Market Value Share (%) and BPS Analysis by Device Type, 2023-2033
Figure 29: North America Neurovascular Devices Market Y-o-Y Growth (%) Projections by Device Type, 2023-2033
Figure 30: North America Neurovascular Devices Market Value (US$ Bn) Analysis by Therapeutic Application, 2018-2033
Figure 31: North America Neurovascular Devices Market Volume (Units) Analysis by Therapeutic Application, 2018-2033
Figure 32: North America Neurovascular Devices Market Value Share (%) and BPS Analysis by Therapeutic Application, 2023-2033
Figure 33: North America Neurovascular Devices Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2023-2033
Figure 34: North America Neurovascular Devices Market Attractiveness by Device Type, 2023-2033
Figure 35: North America Neurovascular Devices Market Attractiveness by Therapeutic Application, 2023-2033
Figure 36: North America Neurovascular Devices Market Attractiveness by Country, 2023-2033
Figure 37: Latin America Neurovascular Devices Market Value (US$ Bn) by Device Type, 2023-2033
Figure 38: Latin America Neurovascular Devices Market Value (US$ Bn) by Therapeutic Application, 2023-2033
Figure 39: Latin America Neurovascular Devices Market Value (US$ Bn) by Country, 2023-2033
Figure 40: Latin America Neurovascular Devices Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 41: Latin America Neurovascular Devices Market Volume (Units) Analysis by Country, 2018-2033
Figure 42: Latin America Neurovascular Devices Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 43: Latin America Neurovascular Devices Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 44: Latin America Neurovascular Devices Market Value (US$ Bn) Analysis by Device Type, 2018-2033
Figure 45: Latin America Neurovascular Devices Market Volume (Units) Analysis by Device Type, 2018-2033
Figure 46: Latin America Neurovascular Devices Market Value Share (%) and BPS Analysis by Device Type, 2023-2033
Figure 47: Latin America Neurovascular Devices Market Y-o-Y Growth (%) Projections by Device Type, 2023-2033
Figure 48: Latin America Neurovascular Devices Market Value (US$ Bn) Analysis by Therapeutic Application, 2018-2033
Figure 49: Latin America Neurovascular Devices Market Volume (Units) Analysis by Therapeutic Application, 2018-2033
Figure 50: Latin America Neurovascular Devices Market Value Share (%) and BPS Analysis by Therapeutic Application, 2023-2033
Figure 51: Latin America Neurovascular Devices Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2023-2033
Figure 52: Latin America Neurovascular Devices Market Attractiveness by Device Type, 2023-2033
Figure 53: Latin America Neurovascular Devices Market Attractiveness by Therapeutic Application, 2023-2033
Figure 54: Latin America Neurovascular Devices Market Attractiveness by Country, 2023-2033
Figure 55: Europe Neurovascular Devices Market Value (US$ Bn) by Device Type, 2023-2033
Figure 56: Europe Neurovascular Devices Market Value (US$ Bn) by Therapeutic Application, 2023-2033
Figure 57: Europe Neurovascular Devices Market Value (US$ Bn) by Country, 2023-2033
Figure 58: Europe Neurovascular Devices Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 59: Europe Neurovascular Devices Market Volume (Units) Analysis by Country, 2018-2033
Figure 60: Europe Neurovascular Devices Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 61: Europe Neurovascular Devices Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 62: Europe Neurovascular Devices Market Value (US$ Bn) Analysis by Device Type, 2018-2033
Figure 63: Europe Neurovascular Devices Market Volume (Units) Analysis by Device Type, 2018-2033
Figure 64: Europe Neurovascular Devices Market Value Share (%) and BPS Analysis by Device Type, 2023-2033
Figure 65: Europe Neurovascular Devices Market Y-o-Y Growth (%) Projections by Device Type, 2023-2033
Figure 66: Europe Neurovascular Devices Market Value (US$ Bn) Analysis by Therapeutic Application, 2018-2033
Figure 67: Europe Neurovascular Devices Market Volume (Units) Analysis by Therapeutic Application, 2018-2033
Figure 68: Europe Neurovascular Devices Market Value Share (%) and BPS Analysis by Therapeutic Application, 2023-2033
Figure 69: Europe Neurovascular Devices Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2023-2033
Figure 70: Europe Neurovascular Devices Market Attractiveness by Device Type, 2023-2033
Figure 71: Europe Neurovascular Devices Market Attractiveness by Therapeutic Application, 2023-2033
Figure 72: Europe Neurovascular Devices Market Attractiveness by Country, 2023-2033
Figure 73: Asia Pacific Neurovascular Devices Market Value (US$ Bn) by Device Type, 2023-2033
Figure 74: Asia Pacific Neurovascular Devices Market Value (US$ Bn) by Therapeutic Application, 2023-2033
Figure 75: Asia Pacific Neurovascular Devices Market Value (US$ Bn) by Country, 2023-2033
Figure 76: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 77: Asia Pacific Neurovascular Devices Market Volume (Units) Analysis by Country, 2018-2033
Figure 78: Asia Pacific Neurovascular Devices Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 79: Asia Pacific Neurovascular Devices Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 80: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Analysis by Device Type, 2018-2033
Figure 81: Asia Pacific Neurovascular Devices Market Volume (Units) Analysis by Device Type, 2018-2033
Figure 82: Asia Pacific Neurovascular Devices Market Value Share (%) and BPS Analysis by Device Type, 2023-2033
Figure 83: Asia Pacific Neurovascular Devices Market Y-o-Y Growth (%) Projections by Device Type, 2023-2033
Figure 84: Asia Pacific Neurovascular Devices Market Value (US$ Bn) Analysis by Therapeutic Application, 2018-2033
Figure 85: Asia Pacific Neurovascular Devices Market Volume (Units) Analysis by Therapeutic Application, 2018-2033
Figure 86: Asia Pacific Neurovascular Devices Market Value Share (%) and BPS Analysis by Therapeutic Application, 2023-2033
Figure 87: Asia Pacific Neurovascular Devices Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2023-2033
Figure 88: Asia Pacific Neurovascular Devices Market Attractiveness by Device Type, 2023-2033
Figure 89: Asia Pacific Neurovascular Devices Market Attractiveness by Therapeutic Application, 2023-2033
Figure 90: Asia Pacific Neurovascular Devices Market Attractiveness by Country, 2023-2033
Figure 91: MEA Neurovascular Devices Market Value (US$ Bn) by Device Type, 2023-2033
Figure 92: MEA Neurovascular Devices Market Value (US$ Bn) by Therapeutic Application, 2023-2033
Figure 93: MEA Neurovascular Devices Market Value (US$ Bn) by Country, 2023-2033
Figure 94: MEA Neurovascular Devices Market Value (US$ Bn) Analysis by Country, 2018-2033
Figure 95: MEA Neurovascular Devices Market Volume (Units) Analysis by Country, 2018-2033
Figure 96: MEA Neurovascular Devices Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 97: MEA Neurovascular Devices Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 98: MEA Neurovascular Devices Market Value (US$ Bn) Analysis by Device Type, 2018-2033
Figure 99: MEA Neurovascular Devices Market Volume (Units) Analysis by Device Type, 2018-2033
Figure 100: MEA Neurovascular Devices Market Value Share (%) and BPS Analysis by Device Type, 2023-2033
Figure 101: MEA Neurovascular Devices Market Y-o-Y Growth (%) Projections by Device Type, 2023-2033
Figure 102: MEA Neurovascular Devices Market Value (US$ Bn) Analysis by Therapeutic Application, 2018-2033
Figure 103: MEA Neurovascular Devices Market Volume (Units) Analysis by Therapeutic Application, 2018-2033
Figure 104: MEA Neurovascular Devices Market Value Share (%) and BPS Analysis by Therapeutic Application, 2023-2033
Figure 105: MEA Neurovascular Devices Market Y-o-Y Growth (%) Projections by Therapeutic Application, 2023-2033
Figure 106: MEA Neurovascular Devices Market Attractiveness by Device Type, 2023-2033
Figure 107: MEA Neurovascular Devices Market Attractiveness by Therapeutic Application, 2023-2033
Figure 108: MEA Neurovascular Devices Market Attractiveness by Country, 2023-2033
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Neurovascular Devices Market
